insights_auto
Why is 000739 up 5.06%?
Dive Deeperchevron_right
000739:SHE
Apeloa Pharmaceutical Co Ltd
CNÂ¥21.58
arrow_upward
+5.06%(+1.04) 1D
Nov 4, 3:04:48 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000739...
Open
CNÂ¥20.38
High
CNÂ¥21.86
Low
CNÂ¥20.38
Mkt. cap
23.79B
Avg. vol.
17.85M
Volume
14.27M
Dividend
1.75%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Oct 8, 2026
P/E ratio
30.98
52-wk high
CNÂ¥28.50
52-wk low
CNÂ¥14.92
EPS
CNÂ¥0.70
Shares outstanding
1.16B
No. of employees
7K
Open
CNÂ¥20.38
High
CNÂ¥21.86
Low
CNÂ¥20.38
Mkt. cap
23.79B
Avg. vol.
17.85M
Volume
14.27M
Dividend
1.75%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Oct 8, 2026
P/E ratio
30.98
52-wk high
CNÂ¥28.50
52-wk low
CNÂ¥14.92
EPS
CNÂ¥0.70
Shares outstanding
1.16B
No. of employees
7K
News stories
From web sources and news partners
Virginia Business
·
17 minutes ago
Accendra Health could be delisted by NYSE
The Defiant
·
16 minutes ago
Nasdaq Approves Listing of Canary’s Staked Injective ETF
The Motley Fool
·
20 minutes ago
The Nasdaq-100 Is Outperforming Nvidia, Microsoft, Amazon, Meta Platforms, Alphabet, and Tesla This Year. Here's My Favorite Low-Cost ETF to Buy the Dip.
Seeking Alpha
·
18 minutes ago
The Average Performance Of The S&P 500 Under A Divided Government Since 1953
Profile
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
About Apeloa Pharmaceutical Co Ltd